Cancer Surgery
Conditions
Interventions
Tranexamic acid
Placebo
Sponsors
Adegoke Ishola
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Adult female breast cancer patients Undergoing modified radical mastectomy
Exclusion criteria
Exclusion criteria: Immediate reconstruction Allergy to tranexamic acid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The volume of daily wound drainage ;The total volume of wound drainage;The occurrence of seroma within 28 days of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical Site Infection;Flap necrosis | — |
Countries
Nigeria
Contacts
Public ContactTemidayo Ogundiran
Professor of Surgery
Outcome results
None listed